Form 4: USANA Health Sciences Executive Sells Shares

Brent Neidig, Chief Commercial Officer of USANA Health Sciences, sold 4,743 shares of common stock at an average price of $32.3397 on March 12, 2025.

Summary

• On March 12, 2025, Brent Neidig, the Chief Commercial Officer of USANA Health Sciences, sold 4,743 shares of the company's common stock.
• The sale was executed at a weighted average price of $32.3397 per share.
• The prices for individual transactions ranged from $32.31 to $32.37.
• Following the transaction, Mr. Neidig directly owns 0 shares of USANA Health Sciences.

Sentiment

Score: 5

Explanation: The document itself is neutral, simply reporting a transaction. The sentiment is neither positive nor negative without additional context.

Industry Context

Executive stock sales are a common occurrence and are often scrutinized by investors for insights into a company's prospects; however, without additional context, it's difficult to ascertain the specific reasons behind this sale.

Stakeholder Impact

• The stock sale could have a minor impact on shareholder sentiment, depending on how the market interprets the transaction.

Key Dates